Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 47.33% is 53% above its 5-year average of 31.02%, near the high end of its 5-year range (0.00%–59.39%).
18.17% above its 12-month average of 40.05%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 50.00%.
GROSS MARGIN
47.33%
GROSS MARGIN AVG TTM
40.05%
GROSS MARGIN AVG 3Y
46.35%
GROSS MARGIN AVG 5Y
31.02%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18.17%
CURRENT VS 3Y AVG
+2.11%
CURRENT VS 5Y AVG
+52.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+14.38%
vs the sector median at left
Quantum-Si incorporated
Market Cap
$241.34M
Gross Margin
47.33%
TTM Avg
40.05%
3Y Avg
46.35%
5Y Avg
31.02%
Market Cap
$241.94M
Gross Margin
N/A
TTM Avg
31.32%
3Y Avg
30.59%
5Y Avg
32.68%
Market Cap
$239.02M
Gross Margin
88.00%
TTM Avg
94.00%
3Y Avg
97.00%
5Y Avg
64.67%
Market Cap
$235.97M
Gross Margin
68.57%
TTM Avg
73.00%
3Y Avg
80.96%
5Y Avg
81.80%
Market Cap
$235.66M
Gross Margin
79.48%
TTM Avg
71.93%
3Y Avg
74.52%
5Y Avg
72.98%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum-Si incorporated (QSI) | $241.34M | 47.33% | 40.05% | 46.35% | 31.02% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 99.84% | 50.00% | 75.00% | 50.00% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | 31.32% | 30.59% | 32.68% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 88.00% | 94.00% | 97.00% | 64.67% |
| High Tide Inc. (HITI)vs › | $239.01M | 25.85% | 26.57% | 27.09% | 30.11% |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 91.35% | 93.31% | 46.66% | 31.10% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | 99.39% | 50.00% | 25.00% | 25.00% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 68.57% | 73.00% | 80.96% | 81.80% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 79.48% | 71.93% | 74.52% | 72.98% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | 100.00% | 100.00% | 18.35% | -18.33% |
Gross Margin
47.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 50.00% |
| 2026-03-31 | 28.68% |
| 2025-12-31 | 27.05% |
| 2025-09-30 | 35.14% |
| 2025-06-30 | 59.39% |
| 2025-03-31 | 57.72% |
| 2024-12-31 | 51.17% |
| 2024-09-30 | 46.63% |
| 2024-06-30 | 56.91% |
| 2024-03-31 | 58.86% |
| 2023-12-31 | 44.50% |
| 2023-09-30 | 48.43% |
| 2023-06-30 | 38.05% |
| 2023-03-31 | 48.82% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
